$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Halifax, Nova Scotia--(Newsfile Corp. - June 3, 2024) - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF), a company focused on silver and gold production in Mexico., is pleased to announce that it will
Argo Completes First Phase of MOU with Connective Global, Secures R&D Facility at University Putra Malaysia
08:00am, Monday, 03'rd Jun 2024
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2024) - Argo Living Soils Corp. (CSE: ARGO) (FSE: 94Y) (OTC Pink: ARLSF) ("Argo") is pleased to announce the successful completion of the first p
AU10TIX Q1 2024 Global Identity Fraud Report Identifies Online Gaming Industry as New ID Fraud Hotspot
08:00am, Monday, 03'rd Jun 2024
Unique View into Large-Scale Organized Identity Fraud Shows That Lax Regulations Continue to Propel Payments Sector Attacks TEL AVIV, Israel , June 3, 2024 /PRNewswire/ -- AU10TIX , a global technolog
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
07:30am, Monday, 03'rd Jun 2024
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the Jeff
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
07:30am, Monday, 03'rd Jun 2024
CORAL GABLES, Fla. , June 3, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announce
Skye Bioscience to Present at Jefferies Global Healthcare Conference
07:00am, Monday, 03'rd Jun 2024
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of no
Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
07:00am, Monday, 03'rd Jun 2024
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class
Carrier Announces Close of $4.95B Sale of its Global Access Solutions Business
06:55am, Monday, 03'rd Jun 2024
Advances Carrier's transformation into a focused global leader in intelligent climate and energy solutions Net proceeds of $4B expected to be used to pay down debt and help reduce net leverage to appr
Kolibri Global Energy Inc. Announces Nickel Hill Production Rates and Inclusion in Russell Index
06:45am, Monday, 03'rd Jun 2024
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Kolibri Global Energy Inc. (the “Company” or “Kolibri”) (TSX: KEI, NASDAQ: KGEI) is pleased to provide an update on its latest wells in its Tishomingo f
Hyatt's Growth Momentum Continues With Record Global Pipeline of 129,000 Rooms
06:30am, Monday, 03'rd Jun 2024
CHICAGO--(BUSINESS WIRE)--Hyatt Hotels Corporation (NYSE: H) highlighted today that its pipeline has grown by nearly 85 percent since 2017, reaching a record 129,000 rooms. This significant growth hig
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
06:00am, Monday, 03'rd Jun 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 3, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will par
Dublin, June 03, 2024 (GLOBE NEWSWIRE) -- The "Global Micro-inverter Market by Offering, Communication Technology (Wired, Wireless), Type (Single Phase, Three Phase), Power Rating (Below 250 W, Betwee
Dublin, June 03, 2024 (GLOBE NEWSWIRE) -- The "Q1 2024 Global Oil & Gas Industry Contracts Review - Tecnicas Reunidas and Sinopec Engineering consortium secure significant contracts for Riyas NGL faci
RIVERWOODS, Ill.--(BUSINESS WIRE)--Discover Global Network®, a leading global payment network, released the first portion of the 2024 Payment State of the Union (PSOU), one of the most comprehensive
Euronext completes the acquisition of Global Rate Set Systems
02:00am, Monday, 03'rd Jun 2024
Contacts Media Contact Investor Relations Amsterdam +31 20 721 4133 Brussels +32 2 620 15 50 +33 1 70 48 24 17 Dublin +39 02 72 42 62 13 Lisbon +351 210 600 614 Milan +39 02 72 42 62 12 Oslo +47 41
Sign In
Buy GTLL